Optimal switching strategies in multidrug therapies for chronic diseases
Open Access
- 10 September 2025
- journal article
- Published by American Physical Society (APS) in Physical Review E
- Vol. 112 (3) , 034408
Abstract
Antimicrobial resistance is a threat to public health with millions of deaths linked to drug-resistant infections every year. To mitigate resistance, common strategies that are used are combination therapies and therapy switching. However, the stochastic nature of pathogenic mutation makes the optimization of these strategies challenging. Here, we propose a two-scale stochastic model that considers the effective evolution of therapies in a multidimensional efficacy space, where each dimension represents the efficacy of a specific drug in the therapy. The diffusion of therapies within this space is subject to stochastic resets, representing therapy switches. The boundaries of the space, inferred from coarser pathogen-host dynamics, can be either reflecting or absorbing. Reflecting boundaries impede full recovery of the host, while absorbing boundaries represent the development of antimicrobial resistance, leading to therapy failure. We derive analytical expressions for the average absorption times, accounting for both continuous and discrete genomic changes using the frameworks of Langevin and master equations, respectively. These expressions allow us to evaluate the relevance of times between drug switches and the number of simultaneous drugs in relation to typical timescales for drug resistance development. To study realistic therapy scenarios, we impose constraints on the number of administered therapies and/or their costs, which reveals nontrivial optimal drug-switching protocols that maximize the time before antimicrobial resistance develops while reducing therapy costs. Finally, we extend the model to consider single-cell heterogeneity to accurately capture the effects of individual mutations that result in drug resistance.Keywords
All Related Versions
Funding Information
- Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033)
- European Regional Development Fund
This publication has 77 references indexed in Scilit:
- A first passage under resetting approach to income dynamicsChaos, Solitons & Fractals, 2023
- Biological research on the occurrence and development of multiple myeloma and its treatmentImmunity, Inflammation and Disease, 2023
- Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform PolicyApplied Health Economics and Health Policy, 2022
- Towards multiscale modeling of the CD8+T cell response to viral infectionsWIREs Mechanisms of Disease, 2019
- Stochastic Numerical Methods2014
- Modelling viral evolution and adaptation: challenges and rewardsCurrent Opinion in Virology, 2012
- The frequency and reasons for antiretroviral switching with specific antiretroviral associations: The SWITCH studyAntiviral Research, 2010
- Optimal investment in HIV prevention programs: more is not always betterHealth Care Management Science, 2008
- HIV-1 Infection and Low Steady State Viral LoadsBulletin of Mathematical Biology, 2002
- Mathematical biology of HIV infections: antigenic variation and diversity thresholdMathematical Biosciences, 1991